Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Pharmalot
Biotech
STAT+
The Readout

The human side of clinical trials & Mike Pence’s biotech reputation

  • Damian Garde
  • Meghana Keshavan

By Damian Garde and Meghana Keshavan July 15, 2016

Reprints
The READOUT
Alex Hogan/STAT

The Readout for July 15, 2016

About the Authors Reprints

Damian Garde

Damian Garde

National Biotech Reporter

Damian Garde covers biotech, is a co-writer of The Readout newsletter, and a co-host of "The Readout LOUD" podcast.

Meghana Keshavan

Meghana Keshavan

Biotech Correspondent

Meghana Keshavan covers biotech and contributes to The Readout newsletter.

Drugmakers push back on a clever tactic employers use…
Drugmakers push back on a clever tactic employers use to avoid paying for specialty medicines
Stéphane Bancel, Bernie Sanders spar over what Moderna owes…
Stéphane Bancel, Bernie Sanders spar over what Moderna owes the federal government
Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo
Regeneron targets obesity, a new microbiome deal, & comparing…
Regeneron targets obesity, a new microbiome deal, & comparing cancer drug costs
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries…
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries & regenerating heart tissue
Docs disagree with FDA on Aduhelm, Swiss giants pinch…
Docs disagree with FDA on Aduhelm, Swiss giants pinch pennies, & one SPAC makes it rain

Recommended Stories